Precigen (PGEN) Change in Account Payables (2012 - 2026)
Precigen (PGEN) posted quarterly Change in Account Payables of -$9.5 million for Q1 2026, down 8030.77% year-over-year from $119950.5 in Q1 2025, and down 245.55% quarter-over-quarter from $6.5 million in Q4 2025.
Powered by 
Analysis
Precigen (PGEN) Change in Account Payables (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Change in Account Payables for 15 consecutive years, with -$9.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 8030.77% year-over-year to -$9.5 million; the TTM figure through Mar 2026 stood at -$628000.0 (up 48.57% YoY), while the FY2025 annual figure was $8.8 million, up 466.04% from the prior year.
- Change in Account Payables declined to -$9.5 million in Q1 2026 per PGEN's latest filing, from $6.5 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.5 million in Q4 2025 and bottomed at -$9.5 million in Q1 2026.
- Historically, Change in Account Payables has averaged -$77375.0 across 5 years, with a median of -$97000.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Account Payables slumped 24800.0% — and 2024, when it soared 1165.46%.
- Precigen's Change in Account Payables stood at $457000.0 in 2022, then plunged by 244.86% to -$662000.0 in 2023, then retreated by 19.03% to -$788000.0 in 2024, then soared by 929.44% to $6.5 million in 2025, then slumped by 245.55% to -$9.5 million in 2026.
- Business Quant data shows PGEN's Change in Account Payables at -$9.5 million in Q1 2026, $6.5 million in Q4 2025, and $1.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 2.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.84 Mn |
| Mar 31, 2026 | -9.51 Mn |
| Dec 31, 2025 | 6.54 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 801,000.00 |
| Mar 31, 2025 | -117,000.00 |
| Dec 31, 2024 | -788,000.00 |
| Sep 30, 2024 | -841,000.00 |
| Jun 30, 2024 | 525,000.00 |
| Mar 31, 2024 | 2.65 Mn |
| Dec 31, 2023 | -662,000.00 |
| Sep 30, 2023 | -223,000.00 |
| Jun 30, 2023 | -1.29 Mn |
| Mar 31, 2023 | -249,000.00 |
| Dec 31, 2022 | -349,000.00 |
| Sep 30, 2022 | 1.69 Mn |
| Jun 30, 2022 | -375,000.00 |
| Mar 31, 2022 | -588,000.00 |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | -1.20 Mn |